PET/MRI helpful in difficult cases of epilepsy: Study Medha Baranwal27 Nov 2021 9:00 AM ISTFrance: Hybrid PET/MR can help in identifying brain lesions causing seizures in patients with drug-resistant epilepsy in cases of failure of standard...
SGLT2 inhibitors may lower anemia risk in diabetes patients, study finds Medha Baranwal26 Nov 2021 11:00 AM ISTJapan: The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) is associated with higher levels of hemoglobin and lower anemia prevalence in...
Dipyridamole, a potential therapeutic option for restless legs syndrome: Study Medha Baranwal26 Nov 2021 10:30 AM ISTSpain: Dipyridamole is an effective and well-tolerated treatment option for restless legs syndrome (RLS), suggests a recent study published in the...
Is screening mammography beyond age 75 years cost-effective? Medha Baranwal26 Nov 2021 9:00 AM ISTUSA: Biennial screening mammography is cost-effective to healthy women up to 80 years old but not annual mammography, according to a recent study....
Patients with diabetes and ESKD on dialysis more prone to blood sugar swings: Study Medha Baranwal25 Nov 2021 10:45 AM ISTUSA: Hypoglycemic crises were found to be three times more common than hyperglycemic crises in a nationwide study of patients with diabetes/end-stage...
Increased PSMA PET/CT may predict chemotherapy response in metastatic prostate cancer: Study Medha Baranwal25 Nov 2021 9:00 AM ISTBelgium: 68Ga-PSMA-11 PET/CT can help predict if patients with metastatic prostate cancer (mPCa) will respond to taxane-based chemotherapy, suggests...
ACG updates guideline on diagnosis and management of GERD Medha Baranwal24 Nov 2021 11:30 AM ISTDiagnosing patients with classic GERD symptoms such as heartburn and regurgitation calls for an 8-week trial of empiric proton pump inhibitors once...
Sacubitril/Valsartan does not best valsartan in patients with advanced heart failure: LIFE Trial Medha Baranwal24 Nov 2021 9:00 AM ISTThe trial found no significant improvements with the combination drug when compared with valsartan in terms of the primary endpoint.USA:...
Tirzepatide aids weight loss, improves metabolic health in type 2 diabetes: Study Medha Baranwal24 Nov 2021 9:00 AM ISTUSA: Tirzepatide use in patients with type 2 diabetes (T2D) positively impacts metabolic profile that can only be partially attributed to weight loss,...
Inhaled ciclesonide no better than placebo for reducing COVID-19 symptoms: JAMA Medha Baranwal23 Nov 2021 9:00 PM ISTUSA: Results from a randomized clinical trial showed that Alvesco (ciclesonide, Covis Pharma) did not achieve the primary efficacy endpoint of a...
ASCO guideline on prevention and management of chemotherapy-induced PN in cancer survivors Medha Baranwal23 Nov 2021 7:00 PM ISTUSA: The American Society of Clinical Oncology (ASCO) has released an updated guideline on the prevention and management of chemotherapy-induced...
Bisphosphonate therapy for over an year may prevent fractures in postmenopausal women with osteoporosis: JAMA Medha Baranwal23 Nov 2021 2:00 PM ISTUSA: A recent study in JAMA Internal Medicine has suggested that bisphosphonate therapy is most likely to benefit women with osteoporosis having a...
